GoodRx Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-8.87	-32.83	-25.25	-293.62	42.44	13.8
Depreciation & Amortization	111.77	57.53	37.64	22.91	15.72	9.81
Share-Based Compensation	104.82	120.23	160.46	397.29	3.75	1.76
Other Operating Activities	-69.43	1.85	5.93	4.77	21.38	19.89
Operating Cash Flow	138.29	146.78	178.78	131.34	83.29	45.25
Operating Cash Flow Growth	-5.78%	-17.90%	36.12%	57.70%	84.05%	-
Capital Expenditures	-55.77	-55.21	-34.46	-35.82	-5.75	-3.46
Acquisitions	0	-155.28	-144.28	-55.79	-31.31	0
Investing Cash Flow	-55.77	-210.5	-178.73	-91.62	-37.06	-3.46
Dividends Paid	0	0	0	0	0	-1,346.36
Share Issuance / Repurchase	-96.64	-92.56	35.02	997.8	4.67	3.35
Debt Issued / Paid	-5.27	-7.03	-7.03	-8.34	-59.45	581.26
Other Financing Activities	-65.48	-20.64	-58.52	-83.65	-	737.01
Financing Cash Flow	-167.4	-120.23	-30.53	905.82	-54.78	-24.73
Net Cash Flow	-84.87	-183.94	-30.48	945.54	-8.55	17.06
Free Cash Flow	82.53	91.57	144.32	95.52	77.54	41.8
Free Cash Flow Growth	-9.87%	-36.55%	51.10%	23.19%	85.52%	-
Free Cash Flow Margin	11.00%	11.95%	19.36%	17.34%	19.97%	16.75%
Free Cash Flow Per Share	0.20	0.22	0.35	0.35	0.34	0.37

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).